UBS Group’s Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock XELAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-400
Closed -$640 10684
2024
Q3
$640 Sell
400
-230
-37% -$366 ﹤0.01% 8860
2024
Q2
$1.07K Sell
630
-206
-25% -$386 ﹤0.01% 8665
2024
Q1
$1.69K Buy
+836
New +$1.25K ﹤0.01% 8078
2023
Q3
Sell
-4
Closed -$16 10116
2023
Q2
$16 Sell
4
-160
-98% -$340 ﹤0.01% 8710
2023
Q1
$489 Sell
164
-7,019
-98% -$16K ﹤0.01% 9013
2022
Q4
$21K Sell
7,183
-2,254
-24% -$8.35K ﹤0.01% 7595
2022
Q3
$46K Buy
9,437
+8,948
+1,830% +$52.7K ﹤0.01% 6438
2022
Q2
$3K Buy
+489
New +$3.33K ﹤0.01% 9394

Other funds holding XELAP

UBS Group's XELAP Position: Q4 2024 in Review

UBS Group sold out of Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock (XELAP) in Q4 2024, closing a stake of 400 shares — an estimated $640 sold.

UBS Group first reported a position in XELAP in Q2 2022 and held it in 8 quarters. The position peaked at $46K in Q3 2022. 6 funds tracked by Wall St. Rank hold XELAP as of Q4 2024.

  • UBS Group reported no remaining Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock position as of Q4 2024 after selling out during the quarter.
  • UBS Group sold 400 Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock shares in Q4 2024, an estimated $640.
  • UBS Group first reported a position in Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock in Q2 2022 and held it in 8 quarters.
  • UBS Group's Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock position peaked at $46K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.